| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |